DarioHealth Corp. has announced the presentation of new research at ISPOR Europe 2025, evaluating the economic impact of its multi-condition digital health platform in employer populations. The study, titled "Preliminary Observational Analysis of Digital Health Platform Associated with Medical Cost Changes in Employer Population," analyzed medical claims data and found a significant reduction in total medical costs for employer members using Dario's platform, with the greatest effect observed among high-risk populations. These results were presented at the conference in Glasgow, Scotland, and represent DarioHealth's first publication using claims data to assess cost outcomes. The company's platform is currently used by employers, health plans, and partners across the U.S. to support chronic condition management.